Salesforce (CRM) stock price recorded further gains in its latest intraday trading, following its rebound from the support of its SMA50, which provided the stock with positive momentum that helped drive these gains. This move comes alongside the stock retesting a previously broken short-term downward trend line, while the RSI has reached extremely oversold levels compared to the stock’s price action, indicating a rapid buildup of additional positive momentum in the near term.

Therefore we expect the stock price to rise in upcoming trading, provided that the $252.30 support level holds, to target the $296.00 resistance level.

Today’s price forecast: Bullish

The price of (ETHUSD) declined in its last intraday trading, due to the stability of the key resistance at $3,235, amid the emergence of the negative signals from the relative strength indicators, attempting to gain bullish momentum that might help it to recover and rise again, amid the continuation of the positive support due to its trading above EMA50, reinforcing the chances of this recovery, especially with the dominance of the main bullish trend on the short-term basis.

Brent crude oil’s prices settled on a rise in its last intraday trading, supported by the emergence of the positive signals from the relative strength indicators, after reaching oversold levels, retesting previously broken bullish corrective trend line on the short-term basis, amid the continuation of the dynamic negative pressure that is represented by its trading below EMA50, reducing the chances of full recovery in the upcoming period.

BTCUSD’s price settles on a decline in its recent intraday trading, amid the emergence of the negative signals from the relative strength indicators, attempting to look for a rising low to take it as a base to help it gain the required bullish momentum for its recovery, amid the dominance of the bullish trend on the short-term basis and its trading alongside trend line, with the continuation of the dynamic pressure that is represented by its trading above EMA50, reinforcing the chances of the recovery on the near-term basis.